CVS Caremark bear steps up

Standpoint Research initiates coverage on CVS Caremark (CVS -0.2%) with a dour Sell rating due to valuation.

The investment firm has a price target of $62 on shares of the drugstore operator.

From other sites
Comments (5)
  • hkimsey
    , contributor
    Comments (185) | Send Message
    $CVS is over-valued at these prices. Good call! Just depends on whether the market will continue to push shares higher.
    19 May 2014, 02:29 PM Reply Like
  • Market DJ
    , contributor
    Comments (1108) | Send Message
    $CVS is under-valued at these prices. Bad Call :) The Market will continue to push shares higher.... $CVS has a better chance of hitting $80 before it ever hits $62.
    19 May 2014, 04:30 PM Reply Like
  • Marc Pollack
    , contributor
    Comments (10) | Send Message
    I'd love to see it go down to $62 so I can buy more!
    19 May 2014, 05:29 PM Reply Like
  • Market DJ
    , contributor
    Comments (1108) | Send Message
    True that! I suppose it could get there with a big Market downturn. I would back up the truck and load up with $CVS at $62 :)
    19 May 2014, 05:50 PM Reply Like
  • hilti
    , contributor
    Comments (22) | Send Message
    I just found Standpoint history
    On April 28,2011 they downgraded CVS from buy to hold. CVS closed at $36.25 that day.
    Words fail me.
    19 May 2014, 09:11 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs